-
Shares in weight-loss drugmaker Eli Lilly fall on disappointing sales
Business - Financial Times - October 30 -
Lilly’s Mounjaro, Zepbound drugs see strong demand. So why did sales disappoint?
Business - MarketWatch - October 30 -
Eli Lilly's quarter was messy. What to do with the stock is more clear-cut
Business - CNBC - October 30 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Business - CNBC - October 30
More from CNBC
-
Qualcomm says it expects $4 billion in PC chip sales by 2029, as company gets traction beyond smartphones
Business - CNBC - 8 hours ago -
U.S. 'industrial renaissance' is fueling a rebound in fundraising, Apollo CEO Marc Rowan says
Business - CNBC - 30 minutes ago -
Trump picks Dr. Oz to lead massive Medicare and Medicaid agency CMS
Business - CNBC - 6 hours ago -
Trump tariffs to push down U.S. growth 'a great deal' going into 2026, Morgan Stanley warns
Business - CNBC - 3 hours ago -
China expectedly keeps benchmark lending rates steady as Beijing assesses stimulus measures
Business - CNBC - 4 hours ago